Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 1
2009 3
2010 1
2011 1
2012 1
2013 3
2014 2
2015 8
2016 3
2017 3
2018 5
2019 5
2020 5
2021 11
2022 19
2023 23
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

93 results

Results by year

Filters applied: . Clear all
Page 1
Immunogenicity and safety of single booster dose of KD-414 inactivated COVID-19 vaccine in adults: An open-label, single-center, non-randomized, controlled study in Japan.
Terada-Hirashima J, Takamatsu Y, Shimizu Y, Uemura Y, Takeuchi JS, Tomita N, Matsuda K, Maeda K, Yamamoto S, Fukunaga A, Ohmagari N, Mikami A, Sonoda K, Ujiie M, Mitsuya H, Sugiura W. Terada-Hirashima J, et al. Among authors: takamatsu y. Hum Vaccin Immunother. 2023 Dec 31;19(1):2193074. doi: 10.1080/21645515.2023.2193074. Epub 2023 Apr 13. Hum Vaccin Immunother. 2023. PMID: 37052247 Free PMC article. Clinical Trial.
Rapid whole genome sequencing methods for RNA viruses.
Misu M, Yoshikawa T, Sugimoto S, Takamatsu Y, Kurosu T, Ouji Y, Yoshikawa M, Shimojima M, Ebihara H, Saijo M. Misu M, et al. Among authors: takamatsu y. Front Microbiol. 2023 Feb 23;14:1137086. doi: 10.3389/fmicb.2023.1137086. eCollection 2023. Front Microbiol. 2023. PMID: 36910229 Free PMC article.
Identification of SARS-CoV-2 Mpro inhibitors containing P1' 4-fluorobenzothiazole moiety highly active against SARS-CoV-2.
Higashi-Kuwata N, Tsuji K, Hayashi H, Bulut H, Kiso M, Imai M, Ogata-Aoki H, Ishii T, Kobayakawa T, Nakano K, Takamune N, Kishimoto N, Hattori SI, Das D, Uemura Y, Shimizu Y, Aoki M, Hasegawa K, Suzuki S, Nishiyama A, Saruwatari J, Shimizu Y, Sukenaga Y, Takamatsu Y, Tsuchiya K, Maeda K, Yoshimura K, Iida S, Ozono S, Suzuki T, Okamura T, Misumi S, Kawaoka Y, Tamamura H, Mitsuya H. Higashi-Kuwata N, et al. Among authors: takamatsu y. Nat Commun. 2023 Feb 25;14(1):1076. doi: 10.1038/s41467-023-36729-0. Nat Commun. 2023. PMID: 36841831 Free PMC article.
Efficacy of convalescent plasma therapy for COVID-19 in Japan: An open-label, randomized, controlled trial.
Saito S, Kutsuna S, Akifumi I, Hase R, Oda R, Terada J, Shimizu Y, Uemura Y, Takamatsu Y, Yasuhara A, Shiratori K, Satake M, Sakamoto N, Miyazaki Y, Shimizu H, Togano T, Matsunaga A, Okuma K, Hamaguchi I, Fujisawa K, Nagashima M, Ashida S, Terada M, Kimura A, Morioka S, Matsubayashi K, Tsuno NH, Kojima M, Kuramitsu M, Tezuka K, Ikebe E, Ishizaka Y, Kenji M, Hangaishi A, Mikami A, Sugiura W, Ohmagari N, Mitsuya H. Saito S, et al. Among authors: takamatsu y. J Infect Chemother. 2023 Sep;29(9):869-874. doi: 10.1016/j.jiac.2023.05.012. Epub 2023 May 11. J Infect Chemother. 2023. PMID: 37178973 Free PMC article. Clinical Trial.
Has COVID-19 suppressed dengue transmission in Nepal?
Pandey BD, Ngwe Tun MM, Pandey K, Dumre SP, Bhandari P, Pyakurel UR, Pokhrel N, Dhimal M, Gyanwali P, Culleton R, Takamatsu Y, Costello A, Morita K. Pandey BD, et al. Among authors: takamatsu y. Epidemiol Infect. 2022 Nov 18;150:e196. doi: 10.1017/S0950268822001790. Epidemiol Infect. 2022. PMID: 36444137 Free PMC article.
Structural insight into Marburg virus nucleoprotein-RNA complex formation.
Fujita-Fujiharu Y, Sugita Y, Takamatsu Y, Houri K, Igarashi M, Muramoto Y, Nakano M, Tsunoda Y, Taniguchi I, Becker S, Noda T. Fujita-Fujiharu Y, et al. Among authors: takamatsu y. Nat Commun. 2022 Mar 4;13(1):1191. doi: 10.1038/s41467-022-28802-x. Nat Commun. 2022. PMID: 35246537 Free PMC article.
93 results